PTPA and Alzheimer disease: Some natural drugs have been shown to inhibit tau hyperphosphorylation in AD animal models through modulating the activity of cyclin-dependent kinase-5 (CDK5) [148], glycogen synthase kinase-3 (GSK3) [149], or PP2A [150] to improve the symptoms of AD.